Persons at clinical high-risk for psychosis (CHR) are characterised by specific
neurocognitive deficits. However, the course of neurocognitive performance during the …

Importance Neurocognitive functioning is a potential biomarker to advance detection,
prognosis, and preventive care for individuals at clinical high risk for psychosis (CHR-P) …

Neurocognitive deficits are a core feature of psychotic disorders, but it is unclear whether
they affect all individuals uniformly. The aim of this systematic review and meta-analysis was …

Findings of neurocognitive dysfunction in subjects at Clinical High Risk for Psychosis (CHR-
P) have been controversial. This meta-analysis systematically examined studies of …

This study aims to meta-analytically characterize the presence and magnitude of within-
group variability across neurocognitive functioning in young people at Clinical High-Risk for …

Objective: To compare neuropsychological performance in people at clinical high risk for
psychosis (CHR), healthy controls (HCs), or subjects with first-episode psychosis (FEP) …

Neurocognitive deficits differ with age during the early stages of psychosis. This study aimed
to explore age-related differences (9–35 years old) in the neurocognitive performance of a …

Background Once psychosis has set in, it is difficult for patients to achieve full recovery.
Prevention of psychosis and early intervention are promising for improving the outcomes of …

Background Individuals at clinical high risk (CHR) for psychosis have become a major focus
for research designed to explore early predictors of transition to full psychosis …

Abstract Background and Hypothesis Youth at clinical high-risk (CHR) for psychosis present
with neuropsychological impairments relative to healthy controls (HC), but whether these …